SCHEMBL17108992

SCHEMBL17108992

c1ccc(-n2c3ccc(-n4c5ccccc5c5c4ccc4c6ccc7c(c8ccccc8n7-c7ccccc7)c6n(-c6ccccc6)c45)cc3c3ncccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ATM Q13315 1/20 0.41
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
PDE4A P27815 6/20 0.34
PDE4B Q07343 5/20 0.34
PDE4C Q08493 5/20 0.34
PDE4D Q08499 5/20 0.34
ALDH1A1 P00352 2/20 0.33
TSHR P16473 2/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
FEN1 P39748 1/20 0.32
LOXL3 P58215 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26329918 0.96 KDM4E (0.43) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL26329906 0.96 KDM4E (0.43) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL26329931 0.95 KDM4E (0.42) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL16484272 0.93 KDM4E (0.42) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL26329914 0.92 L3MBTL1 (0.39) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL26329920 0.92 L3MBTL1 (0.39) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL26329859 0.91 KDM4E (0.46) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL16485710 0.90 KDM4E (0.45) KDM4EL3MBTL1ATMPDE4APDE4B
SCHEMBL26329749 0.89 KDM4E (0.47) KDM4EL3MBTL1ATMPDE4APDE4B
SCHEMBL17264910 0.87 KDM4E (0.50) KDM4EL3MBTL1ATMJAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960364-B2 Ladder compound, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 US disclosed
US-9960364-B2 Ladder compound, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 US disclosed
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMIITSU KOSAN CO., LTD. (JP) 2015-09-24 US disclosed
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMIITSU KOSAN CO., LTD. (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME YBX1, ATXN2L, ATXN2 KDM4E 2405/4885L3MBTL1 106/4885ATM 3393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.